Condition
Exosome Multiomics clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Exosome Multiomics clinical trials that are recruiting, at sites in 2 countries (most in Indonesia (1), China (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
MSC exosome treatment to repair blood vessel damage after preeclampsia
This study will see if IV infusions of mesenchymal stem cell–derived exosomes help repair damaged blood vessels in women who recently had preeclampsia.
-
Evaluating exosome multiomics and clinical outcomes in sudden cardiac death patients
This study looks at how certain tiny particles in the blood are connected to sudden cardiac death in patients who had symptoms before their heart stopped, to help improve future care and prevention.
Related topics
Quick answers
How many Exosome Multiomics clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Indonesia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.